BRCA1 and triple-negative breast carcinoma: We tested the growth inhibitory effects of Tala with and without Deci in this cell line panel, using the triple negative breast cancer cell line SUM149PT as a control with a naturally occurring pathogenic BRCA1 2288delT mutation [33] in a different genetic background.